Valeo Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-300
Closed -$115K – 595
2021
Q2
$115K Buy
+300
New +$115K 0.01% 467

Other funds holding ELV

Valeo Financial Advisors's ELV Position: Q3 2026 in Review

Valeo Financial Advisors reduced its Elevance Health (ELV) stake by 4.1% in Q3 2026, selling an estimated $75.8K and leaving 4,480 shares worth $1.74M. The position accounts for 0.04% of the portfolio, ranked #204.

Valeo Financial Advisors first reported a position in ELV in Q3 2017 and has held it in 37 quarters since. The position peaked at $3.24M in Q4 2022. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Valeo Financial Advisors held 4,480 shares of Elevance Health worth $1.74M as of Q3 2026.
  • Valeo Financial Advisors sold 190 Elevance Health shares in Q3 2026, an estimated $75.8K.
  • Elevance Health made up 0.04% of Valeo Financial Advisors's portfolio in Q3 2026, its #204 holding.
  • Valeo Financial Advisors first reported a position in Elevance Health in Q3 2017 and has held it in 37 quarters since.
  • Valeo Financial Advisors's Elevance Health position peaked at $3.24M in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.